Clinical trials: Chronic Optic Neuropathy in Multiple Sclerosis
- Condition Chronic Optic Neuropathy in Multiple Sclerosis
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
Multiple Sclerosis
A Phase 1/2a Study of Oral PRO-1562 in Healthy Subjects and Patients With Relapsing Multiple Sclerosis
Phase 1 will test single oral doses of PRO-1562 in healthy adult subjects to characterize the safety and the amount of drug that is absorbed into the body.
- Trial name
- NCT07826689
- Testing
- PRO-1562 Oral Capsules
- Where
- Australia
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- Progentos Therapeutics